TRANSENTERIX INC's ticker is TRXC and the CUSIP is 89366M201. A total of 97 filers reported holding TRANSENTERIX INC in Q1 2018. The put-call ratio across all filers is 0.96 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2019 | $6,000 | -57.1% | 10,000 | 0.0% | 0.00% | -100.0% |
| Q2 2019 | $14,000 | -39.1% | 10,000 | 0.0% | 0.00% | 0.0% |
| Q1 2019 | $23,000 | 0.0% | 10,000 | 0.0% | 0.00% | 0.0% |
| Q4 2018 | $23,000 | -60.3% | 10,000 | 0.0% | 0.00% | -50.0% |
| Q3 2018 | $58,000 | +34.9% | 10,000 | 0.0% | 0.00% | 0.0% |
| Q2 2018 | $43,000 | +152.9% | 10,000 | 0.0% | 0.00% | +100.0% |
| Q1 2018 | $17,000 | -55.3% | 10,000 | -50.0% | 0.00% | 0.0% |
| Q4 2017 | $38,000 | +171.4% | 20,000 | +100.0% | 0.00% | – |
| Q3 2017 | $14,000 | +100.0% | 10,000 | 0.0% | 0.00% | – |
| Q2 2017 | $7,000 | -41.7% | 10,000 | 0.0% | 0.00% | – |
| Q1 2017 | $12,000 | -40.0% | 10,000 | -33.8% | 0.00% | -100.0% |
| Q4 2016 | $20,000 | -23.1% | 15,100 | 0.0% | 0.00% | 0.0% |
| Q3 2016 | $26,000 | +44.4% | 15,100 | 0.0% | 0.00% | 0.0% |
| Q2 2016 | $18,000 | -59.1% | 15,100 | +51.0% | 0.00% | 0.0% |
| Q1 2016 | $44,000 | +76.0% | 10,000 | 0.0% | 0.00% | 0.0% |
| Q4 2015 | $25,000 | – | 10,000 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| SV Health Investors, LLC | 7,546,692 | $12,829,000 | 9.62% |
| StepStone Group LP | 3,032,625 | $5,155,000 | 3.79% |
| Aisling Capital LLC | 9,889,352 | $16,812,000 | 3.00% |
| PACIFIC VIEW ASSET MANAGEMENT, LLC | 519,548 | $883,000 | 0.66% |
| INTERNATIONAL BIOTECHNOLOGY TRUST PLC | 889,082 | $1,503,000 | 0.59% |
| MASTERS CAPITAL MANAGEMENT LLC | 4,000,000 | $6,800,000 | 0.15% |
| Tibra Equities Europe Ltd | 335,565 | $570,000 | 0.10% |
| BRANDYWINE MANAGERS, LLC | 94,583 | $161,000 | 0.09% |
| SABBY MANAGEMENT, LLC | 513,430 | $872,000 | 0.05% |
| ACUTA CAPITAL PARTNERS, LLC | 180,000 | $307,000 | 0.05% |